Update on adherence to guidelines for time to initiation of postoperative radiation for head and neck squamous cell carcinoma

被引:12
|
作者
Lorenz, F. Jeffrey [1 ]
Mahase, Sean S. S. [1 ,2 ]
Miccio, Joseph [1 ,2 ]
King, Tonya S. S. [3 ]
Pradhan, Sandeep [3 ]
Goyal, Neerav [1 ,3 ,4 ,5 ]
机构
[1] Penn State Univ, Coll Med, Hershey, PA USA
[2] Penn State Hershey Med Ctr, Dept Radiat Oncol, Hershey, PA USA
[3] Penn State Hershey Med Ctr, Dept Publ Hlth Sci, Hershey, PA USA
[4] Penn State Hershey Med Ctr, Dept Otolaryngol Head & Neck Surg, Hershey, PA USA
[5] Penn State Coll Med, Dept Otolaryngol Head & Neck Surg, 500 Univ Dr MC, Hershey, PA 17033 USA
基金
美国国家卫生研究院;
关键词
head and neck cancer; head and neck squamous cell carcinoma; postoperative radiation; quality care; treatment delay; THERAPY; RADIOTHERAPY; SURVIVAL; SURGERY;
D O I
10.1002/hed.27380
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
BackgroundA prior study reported that over half of patients with HNSCC initiated PORT after 6 weeks from surgery during 2006-2014. In 2022, the CoC released a quality metric for patients to initiate PORT within 6 weeks. This study provides an update on time to PORT in recent years. MethodsThe NCDB and TriNetX Research Network were queried to identify patients with HNSCC who received PORT during 2015-2019 and 2015-2021, respectively. Treatment delay was defined as initiating PORT beyond 6 weeks after surgery. ResultsIn NCDB, PORT was delayed for 62% of patients. Predictors of delay included age >50, female sex, black race, nonprivate insurance/uninsured status, lower education, oral cavity site, negative surgical margins, increased postoperative length of stay, unplanned hospital readmissions, IMRT radiation modality, treatment at an academic hospital or in the Northeast, and surgery and radiation at different facilities. In TriNetX, 64% experienced treatment delay. Additional associations with prolonged time to treatment included never married/divorced/widowed marital status, major surgery (neck dissection/free flaps/laryngectomy), and gastrostomy/tracheostomy dependence. ConclusionsThere continue to be challenges to timely initiation of PORT.
引用
收藏
页码:1676 / 1691
页数:16
相关论文
共 50 条
  • [21] Comparisons of the clinical outcomes of different postoperative radiation strategies for treatment of head and neck squamous cell carcinoma
    Makita, Chiyoko
    Kodaira, Takeshi
    Daimon, Takashi
    Tachibana, Hiroyuki
    Tomita, Natsuo
    Koide, Yutaro
    Koide, Yusuke
    Fukuda, Yujiro
    Nishikawa, Daisuke
    Suzuki, Hidenori
    Hanai, Nobuhiro
    Hasegawa, Yasuhisa
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (12) : 1141 - 1150
  • [22] Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma
    Murakami, Naoya
    Matsumoto, Fumihiko
    Yoshimoto, Seiichi
    Ito, Yoshinori
    Mori, Taisuke
    Ueno, Takao
    Tuchida, Keisuke
    Kashihara, Tairo
    Kobayashi, Kazuma
    Harada, Ken
    Kitaguchi, Mayuka
    Sekii, Shuhei
    Umezawa, Rei
    Takahashi, Kana
    Inaba, Koji
    Igaki, Hiroshi
    Itami, Jun
    BMC CANCER, 2016, 16
  • [23] The effect of time between diagnosis and initiation of treatment on outcomes in patients with head and neck squamous cell carcinoma
    DeGraaf, Luke H.
    Platek, Alexis J.
    Iovoli, Austin J.
    Wooten, Kimberly E.
    Arshad, Hassan
    Gupta, Vishal
    McSpadden, Ryan P.
    Kuriakose, Moni Abraham
    Hicks, Wesley L., Jr.
    Platek, Mary E.
    Singh, Anurag K.
    ORAL ONCOLOGY, 2019, 96 : 148 - 152
  • [24] TIME TO RECURRENCE OF SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    STELL, PM
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1991, 13 (04): : 277 - 281
  • [25] Adherence of head and neck squamous cell carcinoma patients to tumor board recommendations
    Rangabashyam, Mahalakshmi S.
    Lee, Shi Yan
    Tan, Sher Yin
    Mueller, Stefan
    Sultana, Rehena
    Ho, Johnatton
    Skanthakumar, Thakshayeni
    Tan, Ngian Chye
    Tan, Hiang Khoon
    Soo, Khee Chee
    Iyer, N. Gopalakrishna
    CANCER MEDICINE, 2020, 9 (14): : 5124 - 5133
  • [26] Salvage surgery for squamous cell carcinoma of the head and neck in the era of immunotherapy: Is it time to clarify our guidelines?
    Saba, Nabil F.
    Mendenhall, William M.
    Hutcheson, Kate
    Suarez, Carlos
    Wolf, Greg
    Ferlito, Alfio
    CANCER, 2018, 124 (21) : 4163 - 4164
  • [27] Head and neck squamous cell carcinoma
    不详
    Nature Reviews Disease Primers, 6 (1)
  • [28] Squamous cell carcinoma in the head and neck
    Al-Reefy, Hiba
    Dhar, Vikrain
    Dilkes, Mike
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2007, 68 (07) : 380 - 383
  • [29] HEAD AND NECK SQUAMOUS CELL CARCINOMA
    不详
    NATURE REVIEWS DISEASE PRIMERS, 2020, 6 (01):
  • [30] Squamous cell carcinoma of the head and neck
    Lorenz, K. J.
    Maier, H.
    HNO, 2008, 56 (04) : 402 - 409